Regulus Therapeutics Inc (RGLS)
2.41
+0.14
(+6.17%)
USD |
NASDAQ |
Apr 26, 16:00
2.41
0.00 (0.00%)
After-Hours: 16:10
Regulus Therapeutics Total Liabilities (Quarterly): 9.563M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.563M |
| September 30, 2023 | 9.488M |
| June 30, 2023 | 9.65M |
| March 31, 2023 | 10.42M |
| December 31, 2022 | 13.42M |
| September 30, 2022 | 12.46M |
| June 30, 2022 | 11.93M |
| March 31, 2022 | 11.74M |
| December 31, 2021 | 13.50M |
| September 30, 2021 | 14.03M |
| June 30, 2021 | 12.69M |
| March 31, 2021 | 12.73M |
| December 31, 2020 | 11.58M |
| September 30, 2020 | 19.59M |
| June 30, 2020 | 21.20M |
| March 31, 2020 | 20.10M |
| December 31, 2019 | 22.07M |
| September 30, 2019 | 21.55M |
| June 30, 2019 | 20.95M |
| March 31, 2019 | 25.95M |
| December 31, 2018 | 33.78M |
| September 30, 2018 | 33.19M |
| June 30, 2018 | 38.74M |
| March 31, 2018 | 39.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 42.59M |
| September 30, 2017 | 42.26M |
| June 30, 2017 | 41.86M |
| March 31, 2017 | 41.45M |
| December 31, 2016 | 44.59M |
| September 30, 2016 | 43.58M |
| June 30, 2016 | 41.48M |
| March 31, 2016 | 20.91M |
| December 31, 2015 | 17.00M |
| September 30, 2015 | 17.58M |
| June 30, 2015 | 17.64M |
| March 31, 2015 | 18.02M |
| December 31, 2014 | 39.47M |
| September 30, 2014 | 29.94M |
| June 30, 2014 | 31.84M |
| March 31, 2014 | 31.82M |
| December 31, 2013 | 29.61M |
| September 30, 2013 | 36.14M |
| June 30, 2013 | 43.20M |
| March 31, 2013 | 41.16M |
| December 31, 2012 | 41.42M |
| September 30, 2012 | 91.87M |
| June 30, 2012 | 30.70M |
| December 31, 2011 | 84.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.488M
Minimum
Sep 2023
22.07M
Maximum
Dec 2019
14.67M
Average
12.73M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 317.20M |
| ADMA Biologics Inc | 193.98M |
| FibroGen Inc | 585.73M |
| Protara Therapeutics Inc | 10.63M |
| Amylyx Pharmaceuticals Inc | 84.02M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.75M |
| Shareholders Equity (Quarterly) | 21.19M |